Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Market Overview
1.1 Lung Cancer Liquid Biops Product Introduction
1.2 Global Lung Cancer Liquid Biops Market Size Forecast
1.3 Lung Cancer Liquid Biops Market Trends & Drivers
1.3.1 Lung Cancer Liquid Biops Industry Trends
1.3.2 Lung Cancer Liquid Biops Market Drivers & Opportunity
1.3.3 Lung Cancer Liquid Biops Market Challenges
1.3.4 Lung Cancer Liquid Biops Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lung Cancer Liquid Biops Players Revenue Ranking (2023)
2.2 Global Lung Cancer Liquid Biops Revenue by Company (2019-2024)
2.3 Key Companies Lung Cancer Liquid Biops Manufacturing Base Distribution and Headquarters
2.4 Key Companies Lung Cancer Liquid Biops Product Offered
2.5 Key Companies Time to Begin Mass Production of Lung Cancer Liquid Biops
2.6 Lung Cancer Liquid Biops Market Competitive Analysis
2.6.1 Lung Cancer Liquid Biops Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Lung Cancer Liquid Biops Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biops as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Exosomes and RNA
3.1.2 CTCs and ctDNA
3.2 Global Lung Cancer Liquid Biops Sales Value by Type
3.2.1 Global Lung Cancer Liquid Biops Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Lung Cancer Liquid Biops Sales Value, by Type (2019-2030)
3.2.3 Global Lung Cancer Liquid Biops Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Physicians'Office Laboratories
4.1.3 Clinical Diagnostic Laboratories
4.2 Global Lung Cancer Liquid Biops Sales Value by Application
4.2.1 Global Lung Cancer Liquid Biops Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Lung Cancer Liquid Biops Sales Value, by Application (2019-2030)
4.2.3 Global Lung Cancer Liquid Biops Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Lung Cancer Liquid Biops Sales Value by Region
5.1.1 Global Lung Cancer Liquid Biops Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Lung Cancer Liquid Biops Sales Value by Region (2019-2024)
5.1.3 Global Lung Cancer Liquid Biops Sales Value by Region (2025-2030)
5.1.4 Global Lung Cancer Liquid Biops Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Lung Cancer Liquid Biops Sales Value, 2019-2030
5.2.2 North America Lung Cancer Liquid Biops Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Lung Cancer Liquid Biops Sales Value, 2019-2030
5.3.2 Europe Lung Cancer Liquid Biops Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Lung Cancer Liquid Biops Sales Value, 2019-2030
5.4.2 Asia Pacific Lung Cancer Liquid Biops Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Lung Cancer Liquid Biops Sales Value, 2019-2030
5.5.2 South America Lung Cancer Liquid Biops Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Lung Cancer Liquid Biops Sales Value, 2019-2030
5.6.2 Middle East & Africa Lung Cancer Liquid Biops Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lung Cancer Liquid Biops Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Lung Cancer Liquid Biops Sales Value
6.3 United States
6.3.1 United States Lung Cancer Liquid Biops Sales Value, 2019-2030
6.3.2 United States Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Lung Cancer Liquid Biops Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Lung Cancer Liquid Biops Sales Value, 2019-2030
6.4.2 Europe Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Lung Cancer Liquid Biops Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Lung Cancer Liquid Biops Sales Value, 2019-2030
6.5.2 China Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
6.5.3 China Lung Cancer Liquid Biops Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Lung Cancer Liquid Biops Sales Value, 2019-2030
6.6.2 Japan Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Lung Cancer Liquid Biops Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Lung Cancer Liquid Biops Sales Value, 2019-2030
6.7.2 South Korea Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Lung Cancer Liquid Biops Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Lung Cancer Liquid Biops Sales Value, 2019-2030
6.8.2 Southeast Asia Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Lung Cancer Liquid Biops Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Lung Cancer Liquid Biops Sales Value, 2019-2030
6.9.2 India Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
6.9.3 India Lung Cancer Liquid Biops Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Biocept
7.1.1 Biocept Profile
7.1.2 Biocept Main Business
7.1.3 Biocept Lung Cancer Liquid Biops Products, Services and Solutions
7.1.4 Biocept Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.1.5 Biocept Recent Developments
7.2 EntroGen
7.2.1 EntroGen Profile
7.2.2 EntroGen Main Business
7.2.3 EntroGen Lung Cancer Liquid Biops Products, Services and Solutions
7.2.4 EntroGen Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.2.5 EntroGen Recent Developments
7.3 Cynvenio Biosystems
7.3.1 Cynvenio Biosystems Profile
7.3.2 Cynvenio Biosystems Main Business
7.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Products, Services and Solutions
7.3.4 Cynvenio Biosystems Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.3.5 Exosome Diagnostics Recent Developments
7.4 Exosome Diagnostics
7.4.1 Exosome Diagnostics Profile
7.4.2 Exosome Diagnostics Main Business
7.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Products, Services and Solutions
7.4.4 Exosome Diagnostics Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.4.5 Exosome Diagnostics Recent Developments
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Profile
7.5.2 F. Hoffmann-La Roche Main Business
7.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Products, Services and Solutions
7.5.4 F. Hoffmann-La Roche Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.5.5 F. Hoffmann-La Roche Recent Developments
7.6 Clearbridge BioMedics
7.6.1 Clearbridge BioMedics Profile
7.6.2 Clearbridge BioMedics Main Business
7.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Products, Services and Solutions
7.6.4 Clearbridge BioMedics Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.6.5 Clearbridge BioMedics Recent Developments
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Profile
7.7.2 Bio-Rad Laboratories Main Business
7.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Products, Services and Solutions
7.7.4 Bio-Rad Laboratories Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.7.5 Bio-Rad Laboratories Recent Developments
7.8 Agena Bioscience
7.8.1 Agena Bioscience Profile
7.8.2 Agena Bioscience Main Business
7.8.3 Agena Bioscience Lung Cancer Liquid Biops Products, Services and Solutions
7.8.4 Agena Bioscience Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.8.5 Agena Bioscience Recent Developments
7.9 Cancer Genetics
7.9.1 Cancer Genetics Profile
7.9.2 Cancer Genetics Main Business
7.9.3 Cancer Genetics Lung Cancer Liquid Biops Products, Services and Solutions
7.9.4 Cancer Genetics Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.9.5 Cancer Genetics Recent Developments
7.10 CellMax Life
7.10.1 CellMax Life Profile
7.10.2 CellMax Life Main Business
7.10.3 CellMax Life Lung Cancer Liquid Biops Products, Services and Solutions
7.10.4 CellMax Life Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.10.5 CellMax Life Recent Developments
7.11 Nateras
7.11.1 Nateras Profile
7.11.2 Nateras Main Business
7.11.3 Nateras Lung Cancer Liquid Biops Products, Services and Solutions
7.11.4 Nateras Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.11.5 Nateras Recent Developments
7.12 MedGenome
7.12.1 MedGenome Profile
7.12.2 MedGenome Main Business
7.12.3 MedGenome Lung Cancer Liquid Biops Products, Services and Solutions
7.12.4 MedGenome Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.12.5 MedGenome Recent Developments
7.13 OncoDNA
7.13.1 OncoDNA Profile
7.13.2 OncoDNA Main Business
7.13.3 OncoDNA Lung Cancer Liquid Biops Products, Services and Solutions
7.13.4 OncoDNA Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.13.5 OncoDNA Recent Developments
7.14 Genomic Health
7.14.1 Genomic Health Profile
7.14.2 Genomic Health Main Business
7.14.3 Genomic Health Lung Cancer Liquid Biops Products, Services and Solutions
7.14.4 Genomic Health Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.14.5 Genomic Health Recent Developments
7.15 Trovagene
7.15.1 Trovagene Profile
7.15.2 Trovagene Main Business
7.15.3 Trovagene Lung Cancer Liquid Biops Products, Services and Solutions
7.15.4 Trovagene Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.15.5 Trovagene Recent Developments
7.16 Fluxion Biosciences
7.16.1 Fluxion Biosciences Profile
7.16.2 Fluxion Biosciences Main Business
7.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Products, Services and Solutions
7.16.4 Fluxion Biosciences Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.16.5 Fluxion Biosciences Recent Developments
7.17 Biodesix
7.17.1 Biodesix Profile
7.17.2 Biodesix Main Business
7.17.3 Biodesix Lung Cancer Liquid Biops Products, Services and Solutions
7.17.4 Biodesix Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.17.5 Biodesix Recent Developments
7.18 Epic Sciences
7.18.1 Epic Sciences Profile
7.18.2 Epic Sciences Main Business
7.18.3 Epic Sciences Lung Cancer Liquid Biops Products, Services and Solutions
7.18.4 Epic Sciences Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.18.5 Epic Sciences Recent Developments
7.19 Shuwen Biotech
7.19.1 Shuwen Biotech Profile
7.19.2 Shuwen Biotech Main Business
7.19.3 Shuwen Biotech Lung Cancer Liquid Biops Products, Services and Solutions
7.19.4 Shuwen Biotech Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.19.5 Shuwen Biotech Recent Developments
7.20 Personal Genome Diagnostics
7.20.1 Personal Genome Diagnostics Profile
7.20.2 Personal Genome Diagnostics Main Business
7.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Products, Services and Solutions
7.20.4 Personal Genome Diagnostics Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.20.5 Personal Genome Diagnostics Recent Developments
7.21 Predicine
7.21.1 Predicine Profile
7.21.2 Predicine Main Business
7.21.3 Predicine Lung Cancer Liquid Biops Products, Services and Solutions
7.21.4 Predicine Lung Cancer Liquid Biops Revenue (US$ Million) & (2019-2024)
7.21.5 Predicine Recent Developments
8 Industry Chain Analysis
8.1 Lung Cancer Liquid Biops Industrial Chain
8.2 Lung Cancer Liquid Biops Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Lung Cancer Liquid Biops Sales Model
8.5.2 Sales Channel
8.5.3 Lung Cancer Liquid Biops Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Lung Cancer Liquid Biops Market Trends
Table 2. Lung Cancer Liquid Biops Market Drivers & Opportunity
Table 3. Lung Cancer Liquid Biops Market Challenges
Table 4. Lung Cancer Liquid Biops Market Restraints
Table 5. Global Lung Cancer Liquid Biops Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Lung Cancer Liquid Biops Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Lung Cancer Liquid Biops Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Lung Cancer Liquid Biops Product Type
Table 9. Key Companies Time to Begin Mass Production of Lung Cancer Liquid Biops
Table 10. Global Lung Cancer Liquid Biops Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biops as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Lung Cancer Liquid Biops Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Lung Cancer Liquid Biops Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Lung Cancer Liquid Biops Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Lung Cancer Liquid Biops Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Lung Cancer Liquid Biops Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Lung Cancer Liquid Biops Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Lung Cancer Liquid Biops Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Lung Cancer Liquid Biops Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Lung Cancer Liquid Biops Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Lung Cancer Liquid Biops Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Lung Cancer Liquid Biops Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Lung Cancer Liquid Biops Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Lung Cancer Liquid Biops Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Lung Cancer Liquid Biops Sales Value by Region (2019-2024) & (%)
Table 27. Global Lung Cancer Liquid Biops Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Lung Cancer Liquid Biops Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Lung Cancer Liquid Biops Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Lung Cancer Liquid Biops Sales Value, (2025-2030) & (US$ Million)
Table 31. Biocept Basic Information List
Table 32. Biocept Description and Business Overview
Table 33. Biocept Lung Cancer Liquid Biops Products, Services and Solutions
Table 34. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Biocept (2019-2024)
Table 35. Biocept Recent Developments
Table 36. EntroGen Basic Information List
Table 37. EntroGen Description and Business Overview
Table 38. EntroGen Lung Cancer Liquid Biops Products, Services and Solutions
Table 39. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of EntroGen (2019-2024)
Table 40. EntroGen Recent Developments
Table 41. Cynvenio Biosystems Basic Information List
Table 42. Cynvenio Biosystems Description and Business Overview
Table 43. Cynvenio Biosystems Lung Cancer Liquid Biops Products, Services and Solutions
Table 44. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Cynvenio Biosystems (2019-2024)
Table 45. Cynvenio Biosystems Recent Developments
Table 46. Exosome Diagnostics Basic Information List
Table 47. Exosome Diagnostics Description and Business Overview
Table 48. Exosome Diagnostics Lung Cancer Liquid Biops Products, Services and Solutions
Table 49. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Exosome Diagnostics (2019-2024)
Table 50. Exosome Diagnostics Recent Developments
Table 51. F. Hoffmann-La Roche Basic Information List
Table 52. F. Hoffmann-La Roche Description and Business Overview
Table 53. F. Hoffmann-La Roche Lung Cancer Liquid Biops Products, Services and Solutions
Table 54. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of F. Hoffmann-La Roche (2019-2024)
Table 55. F. Hoffmann-La Roche Recent Developments
Table 56. Clearbridge BioMedics Basic Information List
Table 57. Clearbridge BioMedics Description and Business Overview
Table 58. Clearbridge BioMedics Lung Cancer Liquid Biops Products, Services and Solutions
Table 59. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Clearbridge BioMedics (2019-2024)
Table 60. Clearbridge BioMedics Recent Developments
Table 61. Bio-Rad Laboratories Basic Information List
Table 62. Bio-Rad Laboratories Description and Business Overview
Table 63. Bio-Rad Laboratories Lung Cancer Liquid Biops Products, Services and Solutions
Table 64. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Bio-Rad Laboratories (2019-2024)
Table 65. Bio-Rad Laboratories Recent Developments
Table 66. Agena Bioscience Basic Information List
Table 67. Agena Bioscience Description and Business Overview
Table 68. Agena Bioscience Lung Cancer Liquid Biops Products, Services and Solutions
Table 69. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Agena Bioscience (2019-2024)
Table 70. Agena Bioscience Recent Developments
Table 71. Cancer Genetics Basic Information List
Table 72. Cancer Genetics Description and Business Overview
Table 73. Cancer Genetics Lung Cancer Liquid Biops Products, Services and Solutions
Table 74. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Cancer Genetics (2019-2024)
Table 75. Cancer Genetics Recent Developments
Table 76. CellMax Life Basic Information List
Table 77. CellMax Life Description and Business Overview
Table 78. CellMax Life Lung Cancer Liquid Biops Products, Services and Solutions
Table 79. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of CellMax Life (2019-2024)
Table 80. CellMax Life Recent Developments
Table 81. Nateras Basic Information List
Table 82. Nateras Description and Business Overview
Table 83. Nateras Lung Cancer Liquid Biops Products, Services and Solutions
Table 84. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Nateras (2019-2024)
Table 85. Nateras Recent Developments
Table 86. MedGenome Basic Information List
Table 87. MedGenome Description and Business Overview
Table 88. MedGenome Lung Cancer Liquid Biops Products, Services and Solutions
Table 89. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of MedGenome (2019-2024)
Table 90. MedGenome Recent Developments
Table 91. OncoDNA Basic Information List
Table 92. OncoDNA Description and Business Overview
Table 93. OncoDNA Lung Cancer Liquid Biops Products, Services and Solutions
Table 94. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of OncoDNA (2019-2024)
Table 95. OncoDNA Recent Developments
Table 96. Genomic Health Basic Information List
Table 97. Genomic Health Description and Business Overview
Table 98. Genomic Health Lung Cancer Liquid Biops Products, Services and Solutions
Table 99. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Genomic Health (2019-2024)
Table 100. Genomic Health Recent Developments
Table 101. Trovagene Basic Information List
Table 102. Trovagene Description and Business Overview
Table 103. Trovagene Lung Cancer Liquid Biops Products, Services and Solutions
Table 104. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Trovagene (2019-2024)
Table 105. Trovagene Recent Developments
Table 106. Fluxion Biosciences Basic Information List
Table 107. Fluxion Biosciences Description and Business Overview
Table 108. Fluxion Biosciences Lung Cancer Liquid Biops Products, Services and Solutions
Table 109. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Fluxion Biosciences (2019-2024)
Table 110. Fluxion Biosciences Recent Developments
Table 111. Biodesix Basic Information List
Table 112. Biodesix Description and Business Overview
Table 113. Biodesix Lung Cancer Liquid Biops Products, Services and Solutions
Table 114. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Biodesix (2019-2024)
Table 115. Biodesix Recent Developments
Table 116. Epic Sciences Basic Information List
Table 117. Epic Sciences Description and Business Overview
Table 118. Epic Sciences Lung Cancer Liquid Biops Products, Services and Solutions
Table 119. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Epic Sciences (2019-2024)
Table 120. Epic Sciences Recent Developments
Table 121. Shuwen Biotech Basic Information List
Table 122. Shuwen Biotech Description and Business Overview
Table 123. Shuwen Biotech Lung Cancer Liquid Biops Products, Services and Solutions
Table 124. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Shuwen Biotech (2019-2024)
Table 125. Shuwen Biotech Recent Developments
Table 126. Personal Genome Diagnostics Basic Information List
Table 127. Personal Genome Diagnostics Description and Business Overview
Table 128. Personal Genome Diagnostics Lung Cancer Liquid Biops Products, Services and Solutions
Table 129. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Personal Genome Diagnostics (2019-2024)
Table 130. Personal Genome Diagnostics Recent Developments
Table 131. Predicine Basic Information List
Table 132. Predicine Description and Business Overview
Table 133. Predicine Lung Cancer Liquid Biops Products, Services and Solutions
Table 134. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Predicine (2019-2024)
Table 135. Predicine Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Lung Cancer Liquid Biops Downstream Customers
Table 139. Lung Cancer Liquid Biops Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 143. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Lung Cancer Liquid Biops Product Picture
Figure 2. Global Lung Cancer Liquid Biops Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Lung Cancer Liquid Biops Sales Value (2019-2030) & (US$ Million)
Figure 4. Lung Cancer Liquid Biops Report Years Considered
Figure 5. Global Lung Cancer Liquid Biops Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Lung Cancer Liquid Biops Revenue in 2023
Figure 7. Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Exosomes and RNA Picture
Figure 9. CTCs and ctDNA Picture
Figure 10. Global Lung Cancer Liquid Biops Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Lung Cancer Liquid Biops Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospitals and Clinics
Figure 13. Product Picture of Physicians'Office Laboratories
Figure 14. Product Picture of Clinical Diagnostic Laboratories
Figure 15. Global Lung Cancer Liquid Biops Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Lung Cancer Liquid Biops Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Lung Cancer Liquid Biops Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Lung Cancer Liquid Biops Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Lung Cancer Liquid Biops Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Lung Cancer Liquid Biops Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Lung Cancer Liquid Biops Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Lung Cancer Liquid Biops Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Lung Cancer Liquid Biops Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Lung Cancer Liquid Biops Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Lung Cancer Liquid Biops Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Lung Cancer Liquid Biops Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Lung Cancer Liquid Biops Sales Value (%), (2019-2030)
Figure 28. United States Lung Cancer Liquid Biops Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Lung Cancer Liquid Biops Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Lung Cancer Liquid Biops Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Lung Cancer Liquid Biops Sales Value by Application (%), 2023 VS 2030
Figure 34. China Lung Cancer Liquid Biops Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
Figure 36. China Lung Cancer Liquid Biops Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Lung Cancer Liquid Biops Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Lung Cancer Liquid Biops Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Lung Cancer Liquid Biops Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Lung Cancer Liquid Biops Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Lung Cancer Liquid Biops Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Lung Cancer Liquid Biops Sales Value by Application (%), 2023 VS 2030
Figure 46. India Lung Cancer Liquid Biops Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Lung Cancer Liquid Biops Sales Value by Type (%), 2023 VS 2030
Figure 48. India Lung Cancer Liquid Biops Sales Value by Application (%), 2023 VS 2030
Figure 49. Lung Cancer Liquid Biops Industrial Chain
Figure 50. Lung Cancer Liquid Biops Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation